Bellerophon Therapeutics, Inc.
BLPHDelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001600132
Bellerophon Therapeutics, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Oct 16, 2023; 22 institutions reported holding it in 13F filings for Q3 2023, worth $506.6K in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Bellerophon Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 27 | 22 | −5 |
| Shares | 1.31M | 1.18M | −125.6K (−9.6%) |
| Value | $6.34M | $4.81M | −$1.53M (−24.1%) |
New holders (1)
Institutions that held Bellerophon Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Northwestern Mutual Wealth Management Co | 500 | $2.00K | 0.00% |
Sold out (6)
Institutions that held Bellerophon Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| First Trust Advisors LP | 20,515 | $99.0K |
| Virtu Financial LLC | 16,495 | $80.0K |
| Ergoteles LLC | 13,800 | $67.0K |
| Millennium Management LLC | 12,243 | $59.0K |
| New York State Common Retirement Fund | 37 | $0 |
| Citigroup Inc | 50 | $0 |